Immunological tolerance and tumor rejection in embryo-aggregated chimeric mice – Lessons for tumor immunity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Immunological tolerance and tumor rejection in embryo-aggregated chimeric mice – Lessons for tumor immunity ; volume:8 ; number:1 ; day:16 ; month:12 ; year:2008 ; pages:1-12 ; date:12.2008
BMC cancer ; 8, Heft 1 (16.12.2008), 1-12, 12.2008
- Creator
-
Wagner, Alexander Y.
- Contributor
-
Holle, Eric
Holle, Lori
Yu, Xianzhong
Schwamberger, Günter
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-8-370
- URN
-
urn:nbn:de:1111-2016030345965
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
07.04.2024, 4:49 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wagner, Alexander Y.
- Holle, Eric
- Holle, Lori
- Yu, Xianzhong
- Schwamberger, Günter
- SpringerLink (Online service)
Other Objects (12)
TGFbeta blocks IFNalpha/beta release and tumor rejection in spontaneous mammary tumors : = TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors
Tumor Microenvironment‐Triggered Aggregated Magnetic Nanoparticles for Reinforced Image‐Guided Immunogenic Chemotherapy
The immunological basis of tumor therapy by targeted delivery of TNFa to tumor vessels
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth
Chimeric antigen receptor T cells: a novel therapy for solid tumors
Localized oncolytic virotherapy inflames distant tumors and synergizes with immune checkpoint blockade leading to systemic tumor rejection
Novel immunological mechanisms of targeting tumors and their micro-environment
Immunotherapy of solid tumors: multimodal imaging strategies for chimeric antigen receptor T cell tracking in the tumor microenvironment
Harnessing Tumor Cell‐Derived Exosomes for Immune Rejection Management in Corneal Transplantation
Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
TGFbeta blocks IFNalpha/beta release and tumor rejection in spontaneous mammary tumors : = TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors
Tumor Microenvironment‐Triggered Aggregated Magnetic Nanoparticles for Reinforced Image‐Guided Immunogenic Chemotherapy
The immunological basis of tumor therapy by targeted delivery of TNFa to tumor vessels
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth
Chimeric antigen receptor T cells: a novel therapy for solid tumors
Localized oncolytic virotherapy inflames distant tumors and synergizes with immune checkpoint blockade leading to systemic tumor rejection
Novel immunological mechanisms of targeting tumors and their micro-environment
Immunotherapy of solid tumors: multimodal imaging strategies for chimeric antigen receptor T cell tracking in the tumor microenvironment
Harnessing Tumor Cell‐Derived Exosomes for Immune Rejection Management in Corneal Transplantation
Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
TGFbeta blocks IFNalpha/beta release and tumor rejection in spontaneous mammary tumors : = TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors
Tumor Microenvironment‐Triggered Aggregated Magnetic Nanoparticles for Reinforced Image‐Guided Immunogenic Chemotherapy
The immunological basis of tumor therapy by targeted delivery of TNFa to tumor vessels
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth
Chimeric antigen receptor T cells: a novel therapy for solid tumors
Localized oncolytic virotherapy inflames distant tumors and synergizes with immune checkpoint blockade leading to systemic tumor rejection
Novel immunological mechanisms of targeting tumors and their micro-environment
Immunotherapy of solid tumors: multimodal imaging strategies for chimeric antigen receptor T cell tracking in the tumor microenvironment
Harnessing Tumor Cell‐Derived Exosomes for Immune Rejection Management in Corneal Transplantation